Sign in →

Test ID ARBI Acetylcholine Receptor (Muscle AChR) Binding Antibody, Serum

Useful For

A first-order test for the laboratory diagnosis of myasthenia gravis (MG)

 

Detecting "subclinical MG" in recipients of D-penicillamine, in patients with thymoma without clinical evidence of MG, and in patients with graft-versus-host disease

 

Distinguishing acquired disease (90% positive) from congenital disease (negative)

 

Monitoring disease progression in MG or response to immunotherapy

 

An adjunct to the test for P/Q-type calcium channel binding antibodies as a diagnostic aid for Lambert-Eaton myasthenic syndrome (LES) or primary lung carcinoma

Method Name

Radioimmunoassay (RIA)

Reporting Name

ACh Receptor (Muscle) Binding Ab

Specimen Type

Serum


Specimen Required


Patient Preparation: This test should not be requested in patients who have recently received radioisotopes, therapeutically or diagnostically, because of potential assay interference. The specific waiting period before specimen collection will depend on the isotope administered, the dose given and the clearance rate in the individual patient. Specimens will be screened for radioactivity prior to analysis. Radioactive specimens received in the laboratory will be held 1 week and assayed if sufficiently decayed, or canceled if radioactivity remains.

Container/Tube:

Preferred: Red top

Acceptable: Serum gel

Specimen Volume: 1.5 mL


Specimen Minimum Volume

1 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 28 days
  Frozen  28 days
  Ambient  72 hours

Reference Values

≤0.02 nmol/L

Day(s) and Time(s) Performed

Monday through Friday 11 a.m., 6 p.m., and 10 p.m.; Saturday 6 a.m.; Sunday 6 a.m. and 10 a.m.

Performing Laboratory

Mayo Medical Laboratories in Rochester

CPT Code Information

83519

LOINC Code Information

Test ID Test Order Name Order LOINC Value
ARBI ACh Receptor (Muscle) Binding Ab 11034-6

 

Result ID Test Result Name Result LOINC Value
8338 ACh Receptor (Muscle) Binding Ab 11034-6

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

Testing Algorithm

This is the primary diagnostic test for myasthenia gravis.

 

See the following algorithms in Special Instructions:

Myasthenia Gravis Evaluation with MuSK Reflex Algorithm

Myasthenia Gravis/Lambert Eaton Syndrome Diagnostic Algorithm

Myasthenia Gravis: Adult Diagnostic Algorithm

Myasthenia Gravis: Pediatric Diagnostic Algorithm

Myasthenia Gravis: Thymoma Diagnostic Algorithm

Forms

If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen (http://www.mayomedicallaboratories.com/it-mmfiles/neurology-request-form.pdf)